Journal of Translational Medicine

Table 1 Immunoreagents used in this study

From: Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma

Antibody specificity	Fluorescent label	Manufacturer
HLA-ABC	PE^a	BD Pharmingen
HLA-DR	FITC	Biosource^b
CD14	PE	eBioscience
CD40	FITC	BD Pharmingen
CD54	PE	Biosource
CD80	FITC	BD Pharmingen
CD83	PE	Immunotech^c
CD86	FITC	Ancell ^d
CD209	FITC	eBioscience
CCR7	FITC	R&D Systems
IgG	PE	Biosource

^a FITC, fluorescein isothiocyanate; PE, phycoerythrin; APC, allophycocyanin; ^b Camarillo, CA; ^c Miami, FL; ^d Bayport, MN.

Back to article page

ISSN: 1479-5876

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com